Guardant Health
GH
#1740
Rank
HK$90.48 B
Marketcap
HK$689.81
Share price
1.76%
Change (1 day)
93.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of December 2025 : HK$13.39 Billion

According to Guardant Health 's latest financial reports the company's total debt is HK$13.39 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2025-12-31HK$13.30 B28.28%
2024-12-31HK$10.37 B-1.9%
2023-12-31HK$10.57 B-1.17%
2022-12-31HK$10.69 B-0.12%
2021-12-31HK$10.71 B61.71%
2020-12-31HK$6.62 B2005.53%
2019-12-31HK$0.31 B
2018-12-31N/A-100%
2017-12-31HK$5.14 M-96.1%
2016-12-31HK$0.13 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Neogen
NEOG
HK$6.20 B-53.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
HK$1.67 B-87.46%๐Ÿ‡บ๐Ÿ‡ธ USA